Skip to content
Study details
Enrolling now

CV CARE: CardioVascular Care in PC Patients

Dana-Farber Cancer Institute
NCT IDNCT06202820ClinicalTrials.gov data as of Apr 2026
Target enrollment

180

Study length

about 3 years

Ages

18+

Sex

Male only

Locations

2 sites in MA

What this study is about

This trial is testing a program to assess and manage reversible cardiovascular (CV) risk factors in men with prostate cancer starting androgen deprivation therapy (ADT). The goal is to integrate this program into Dana-Farber Cancer Institute clinics for all such participants. This program, called CV Care, involves behavioral interventions.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in CV Care Program

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Proportion of Participants on Blood Pressure Medications in CV CARE, Proportion of Participants on Blood Pressure Medications in CV CARE 2, Proportion of Participants with Blood Pressure Below 130/85 (mmHg) in CV CARE, Proportion of Participants with Blood Pressure Below 130/85 (mmHg) in CV CARE 2

Body systems

Cardiology / Heart, Oncology